STEPHY.T.P, SREEJITH. K, and Dr. BINDU G, “Comparison of quality of life (QOL) for patients with breast Cancer receiving adjuvant tac (docetaxel, doxorubicin, Cyclophosphamide) and fac (5-fluorouracil, doxorubicin, Cyclophosphamide) therapy”, ijpbs, vol. 8, no. 3, pp. 373–382, Sep. 2017.